Fusion Partner for Production of Monoclonal Rabbit Antibodies
AssigneeEpitomics, Inc. (c/o Abcam plc)
InventorsROBERT PYTELA, WEIMIN ZHU, YAOHUANG KE, QI QIAN, HARRY C. AU
Life of this patent
Estimating the term…
Loading patent…
AssigneeEpitomics, Inc. (c/o Abcam plc)
InventorsROBERT PYTELA, WEIMIN ZHU, YAOHUANG KE, QI QIAN, HARRY C. AU
Estimating the term…
The invention provides a rabbit-derived immortal B-lymphocyte capable of fusion with a rabbit splenocyte to produce a hybrid cell that produces an antibody. The immortal B-lymphocyte does not detectably express endogenous immunoglobulin heavy chain and may contain, in certain embodiments, an altered immunoglobulin heavy chain-encoding gene. A hybridoma resulting from fusion between the subject immortal B-lymphocyte and a rabbit antibody-producing cell is provided, as is a method of using that hybridoma to produce an antibody. The subject invention finds use in a variety of different diagnostic, therapeutic and research applications.
1-15. (canceled)
A rabbit-derived immortal B-lymphocyte capable of fusing with a rabbit splenocytes to produce a hybrid cell that produces an immunoglobulin, wherein the rabbit-derived immortal B-lymphocyte fuses with rabbit splenocytes a rate of at least 40%.
Dependencies are inferred from the claim text.